News and Articles

Eliminate Varicose Veins with Invisible Veins, a Product of Pharmaco LLC

Berkshire Information Systems, Inc., (Berkshire) a leading provider of e-commerce fulfillment solutions through e2e-store, announced the launch of their newest e-commerce site with Pharmaco LLC. Pharmaco LLC is the supplier of Invisible Veins, a vascular support product and dietary supplement.

New York City Skin Care Leader Juva Skin Introduces HarmonyXL for Treatment of 60-plus Skin Applications

HarmonyXL could be the answer to the prayers of consumers who seek less invasive skin rejuvenation. The multi-functional device's antiaging secret is its combination of light- and laser-based treatment approaches, which targets a variety of skin concerns and types with less post-treatment recovery time. The skin treatment innovation is now available to patients of Manhattan's Juva Skin and Laser Center.

VNUS Medical Technologies to Present at UBS Global Life Sciences Conference

SAN JOSE, Calif., Sept. 16 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the UBS Global Life Sciences Conference, to be held September 22-25, 2008, at the Grand Hyatt Hotel in New York City.

338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment

SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced that the pivotal clinical study of Polidocanol, conducted in Germany by BioForm Medical's partner, Chemische Fabrik KREUSSLER & Co. GmbH (Kreussler), successfully met the study primary endpoint and has been submitted to FDA as part of a New Drug Application (NDA) process.

Venous Surgery EMR: SonoSoft Chooses Practice Management Solution MPMsoft as its Medical Billing Software

SAN FRANCISCO, Sept. 1 /PRNewswire/ -- As baby boomers age, varicose veins can signal health concerns of not merely unsightly veins, but sometimes painful ulcers that can be a harbinger of a potential for stroke. Fortunately, a fairly simple procedure of laser surgery exists that can reduce the risk of serious complications.

Soluna MD --- The Place For Beauty --- Receives Top Honor From Cynosure, Owner Of Smartlipo Laser Body Sculpting.

Cynosure designates Soluna MD as an official trainer and clinical reference center for Smartlipo. So, why go anywhere else for physician training or to attain this revolutionary, minimally invasive procedure that offers superior body sculpting and skin-tightening results?

Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status

SHAANXI, China, July 29 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio- Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and raw materials used in the production of pharmaceuticals, nutraceuticals and food production, today released an investor update on the status of its application for COS approval for the delivery of Diosmin to Safic-Alcan.

Survey Shows People With Varicose Veins Unaware of Health Risks; Most Never Consider Treatment

CHICAGO, July 29 /PRNewswire/ -- Varicose veins -- unsightly bulging veins in the legs -- force many embarrassed sufferers to cover up, even on the hottest summer days. While often dismissed as a cosmetic issue, varicose veins actually can develop into serious health problems. According to a new survey, many who suffer from varicose veins aren't aware of this and are not seeking treatment for their condition. The survey, sponsored by Vein Clinics of America, found that one in five people reported having varicose veins, and half (48 percent) also experienced aching pain in the legs. Surprisingly, most people (87 percent) reported they have never sought treatment and nearly half (42 percent) do not consider varicose veins to be a serious health issue.

VNUS Medical Technologies to Present at BMO Capital Markets 2008 Focus on Healthcare Conference

SAN JOSE, Calif., July 28 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the BMO Capital Markets 2008 Focus on Healthcare Conference, to be held August 5-6, 2008, at the Millennium Broadway Hotel in New York City.

Minimally Invasive Treatment Improves Male Fertility

A minimally invasive treatment for a common cause of male infertility can significantly improve a couple's chances for pregnancy, according to a new study published in the August issue of Radiology.

VNUS Medical Technologies to Report Second-Quarter 2008 Results and Webcast Teleconference on July 29

SAN JOSE, Calif., July 14 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, announced today that it plans to report its financial results for the second quarter ended June 30, 2008, after the close of market on July 29.

VNUS Medical Technologies, Inc. Announces Board of Director Resignation

SAN JOSE, Calif., July 11 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, announced today the resignation of Kathleen D. LaPorte from the Board of Directors. Ms. LaPorte has served on VNUS' Board of Directors since April 1997 and was a general partner in a venture capital firm that funded the company during its start-up activities. There are no immediate plans for a replacement Director.

VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch

SAN JOSE, Calif., July 2 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, announced today that it has asserted patent infringement claims in the United States District Court, Northern District of California, against biolitec Inc. (Biolitec), Dornier MedTech America, Inc. (Dornier) and NewStar Lasers, Inc. d/b/a CoolTouch, Inc. (CoolTouch).

oh2 Vein Treatment Spa in Atlanta Offers New Treatment for Varicose Veins

ATLANTA, June 26 /PRNewswire/ -- Rarely written about, seldom spoken of, and often times left untreated, vein disease negatively affects the lives of an astonishing 40% of women and 25% of men. Bulging, knotted, twisted varicose veins take over legs and turn what once were ordinary tasks and activities into painful ordeals.

Consumers Union Supports Proposed Expansion of Medicare Policy to Withhold Payments to Hospitals That Harm Patients

Non-Payment Plan Aims to Reduce Preventable Hospital Acquired Infections & Medical Errors

VNUS Medical Technologies to Present at William Blair & Company's 28th Annual Growth Stock Conference

SAN JOSE, Calif., June 16 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the William Blair & Company 28th Annual Growth Stock Conference, to be held June 17-19, 2008, at the Four Seasons Hotel in Chicago, IL.

VNUS Update and Correction to 2008 Royalty Revenues

SAN JOSE, Calif., June 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS) updates and corrects its estimate of royalty revenues for 2008. Royalty revenues in 2008 are estimated to be $12.5 to $12.9 million which is changed from the previously announced royalty revenues of $11.3 to $11.7 million.

VNUS Announces Settlement of Patent Litigation with AngioDynamics and Vascular Solutions

SAN JOSE, Calif., June 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS) today announced that it has entered into an Agreement with AngioDynamics (Nasdaq: ANGO) and Vascular Solutions (Nasdaq: VASC) that settles and resolves the patent infringement lawsuit between the companies filed in 2005. The Agreement results in VNUS granting to AngioDynamics and Vascular Solutions, a non-exclusive, non-sublicensable patent license that covers certain products such as disposable endovenous laser fiber kits, laser fibers, and lasers used in the field of endovenous laser ablation.

Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008

LAS VEGAS, May 29 /PRNewswire/ -- Alma Lasers Ltd. ("Alma Lasers"), a global developer and marketer of laser, light, and radiofrequency based aesthetic devices, announced today at THE Aesthetic Show 2008 FDA clearance for its Harmony(XL), the newest platform for multiple aesthetic laser and light treatments. The Harmony(XL) can be used to treat more than 60 popular aesthetic indications and applications, including acne, skin rejuvenation, hair removal, varicose veins, stretch marks, tattoo removal, wrinkles and skin tightening.

Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Technologies

PORTLAND, Ore., May 28 /PRNewswire/ -- Today, Dr. F. Douglas Day, M.D., Founder and Medical Director of Day Medical Salon, announced the launch of the Oregon Cosmetic Vein Center (OCVC). The OCVC (http://www.oregoncosmeticveincenter.com) is one of the first West Coast vein clinics to offer the CoolTouch CTEV(R) Vein Removal Procedure and other new, FDA-approved treatments and technologies. The OCVC's investment in the very latest equipment and training delivers better results in fewer visits, a potential savings of money, time and discomfort for clients. The OCVC is conveniently located in the medical suites on the third floor of Portland's Lloyd Center Mall.